•Hypo-fractionated dosing patterns and regimens vary among institutions.•For five fractions, tumor control rate: 95%.•Hearing preservation rate: 37%.•Facial, and trigeminal nerve preservation rates: 97%, and 98%, respectively.•No significant correlation between dose and tumor diameter with clinical outcomes.
Clinical Neurology and Neurosurgery – Elsevier
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud